While ramalin demonstrated clear benefits in terms of cognitive function and reductions in key AD‐related pathologies—including Aβ plaques, phosphorylated tau, and neuroinflammation—the precise molecular mechanisms underlying its effects require further elucidation. Here, MAPT is linked to Alzheimer disease.